◼ Archived
Business
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Gip
1 trends tracked about this subject — the full history, oldest to newest below.